首页 | 本学科首页   官方微博 | 高级检索  
检索        

参芪十一味胶囊对晚期非小细胞肺癌的辅助治疗作用
引用本文:童皖宁,卓安山,曹玉书,徐世林.参芪十一味胶囊对晚期非小细胞肺癌的辅助治疗作用[J].国际中医中药杂志,2011,33(12):1060-1063.
作者姓名:童皖宁  卓安山  曹玉书  徐世林
作者单位:解放军第四一一医院呼吸内科,上海,200081
摘    要:目的 观察参芪十一味胶囊对晚期非小细胞肺癌化疗患者的辅助治疗作用.方法 按随机数字表法将58例患者随机分为两组各29例,B组采用吉西十他滨顺铂(GP)方案治疗:第1、8天静脉注射吉西他滨(健泽)1000 mg/m2,30 min内注完;第1天静脉滴注顺铂(DDP) 75 mg/m2.化疗3周为1个周期,连用2个周期.临...

关 键 词:参芪十一味胶囊  辅助治疗  晚期非小细胞肺癌  化疗

Clinic observation on shenqi 11 flavor capsule as adjuvant treatment in advanced NSCLC patients during chemotherapy
TONG Wan-ning,ZHUO An-shan,CAO Yu-shu,XU Shi-lin.Clinic observation on shenqi 11 flavor capsule as adjuvant treatment in advanced NSCLC patients during chemotherapy[J].International Journal of Traditional Chinese Medicine,2011,33(12):1060-1063.
Authors:TONG Wan-ning  ZHUO An-shan  CAO Yu-shu  XU Shi-lin
Abstract:Objective To evaluate the clinical effects and immune function of shenqi 11 flavor capsule as an adjuvant treatment in advanced NSCLC patients during chemotherapy.Methods 58 cases of advanced NSCLC were divided into two groups by mean of digital random table method,with 29 patients in each group.GP scheme chemotherapy was applied to patients in group B,using gemcitabine (1000 mg/m2) on the 1st and 8th day intravenously (procedure should be finished within 30 minutes) and cisplatin (75 mg/m2) on the 1st day intravenously.Each cycle was 3 weeks,two cycles in total.Same scheme was applied to patients in group A and with an addition of shenqi 11 flavor capsule(1.65 g/time,3 times/d) throughout the whole procedure of chemothrapy.Recent curative effect,life quality,toxic reactions and changes in immune indexes of both groups were observed.Results Short-term response rate in group A was 48.27% and 41.38% in the group B (x2=0.279,P>0.05),which showed no significant differences between the two groups.Toxic reactions such as leukopenia,hematochrome decrease and gastrointestinal reactions in the group B were significantly severe compared to group A after chemotherapy(x2 were 4.678,4.549 and 4.687 respectively,P<0.05).As for immune indexes after chemotherapy,CD3+ (55.21 ± 3.28) %,CD4+ (38.84±5.13) %,CD8+ (29.86±4.83) %,CD4+/CD8+( 1.29± 0.17) and NK cells (20.12± 2.11 ) %in the group B indicated significant differences compared to those in group A(62.96±4.12)%、(45.21±3.43)%、(25.23±2.79)%、(1.82±0.21)、(25.78±3.36)%],(P<0.05).The life quality was 58.62% in group A and 31.03% in the group B,which showed significant difference (x2=4.462,P<0.05).Conclusion Shenqi 11 flavor capsule as an adjuvant treatment in advanced NSCLC patients during chemotherapy can not only improve life quality of patients,alleviate the symptoms,but also enhance their immune function.
Keywords:Shenqi 11 flavor capsule  Adjuvant treatment  Advanced non-small cell lung cancer (NSCLC)  Chemotherapy
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号